Dr. Maro Ohanian
Claim this profileM D Anderson Cancer Center
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Acute Myeloid Leukemia
9 reported clinical trials
19 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
Philadelphia chromosome positive
BCR-ABL negative
BCR-ABL1 positive
2Acute Myeloid Leukemia
Philadelphia chromosome positive
t(8;21) negative
inv(16) negative
Affiliated Hospitals
Clinical Trials Maro Ohanian is currently running
Dexrazoxane
for Blood Cancer Side Effects
This phase II trial studies how well dexrazoxane hydrochloride works in preventing heart-related side effects of chemotherapy in participants with blood cancers, such as acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia, and myeloproliferative neoplasms. Chemoprotective drugs, such as dexrazoxane hydrochloride, may protect the heart from the side effects of drugs used in chemotherapy, such as cladribine, idarubicin, cytarabine, and gemtuzumab ozogamicin, in participants with blood cancers.
Recruiting1 award Phase 219 criteria
BP1002 + Decitabine
for Acute Myeloid Leukemia
This study evaluates the safety and tolerability of escalating doses of BP1002 (Liposomal Bcl-2 Antisense Oligodeoxynucleotide) in patients with refractory/relapsed AML. The study is designed to assess the safety profile, identify DLTs, biologically effective doses, PK, PD and potential anti-leukemic effects of BP1002 as single agent (dose escalation phase) followed by assessing BP1002 in combination with decitabine (dose expansion phase).
Recruiting1 award Phase 111 criteria
More about Maro Ohanian
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Maro Ohanian has experience with
- Decitabine
- Bortezomib
- Clofarabine
- Cyclophosphamide
- Dexamethasone
- Etoposide
Breakdown of trials Maro Ohanian has run
T-Lymphoblastic Leukemia/Lymphoma
Acute Myeloid Leukemia
Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maro Ohanian specialize in?
Maro Ohanian focuses on T-Lymphoblastic Leukemia/Lymphoma and Acute Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved Philadelphia chromosome positive patients, or patients who are BCR-ABL negative.
Is Maro Ohanian currently recruiting for clinical trials?
Yes, Maro Ohanian is currently recruiting for 5 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Maro Ohanian has studied deeply?
Yes, Maro Ohanian has studied treatments such as Decitabine, Bortezomib, Clofarabine.
What is the best way to schedule an appointment with Maro Ohanian?
Apply for one of the trials that Maro Ohanian is conducting.
What is the office address of Maro Ohanian?
The office of Maro Ohanian is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.